메뉴 건너뛰기




Volumn 12, Issue 4, 2012, Pages 280-283

Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: An antibody-drug conjugate for CD30-positive lymphoid neoplasms

Author keywords

Anaplastic large cell lymphoma; Brentuximab vedotin; Classic Hodgkin lymphoma; Internalization kinetics; SGN 35

Indexed keywords

BRENTUXIMAB VEDOTIN; CD30 ANTIGEN;

EID: 84864196688     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.01.012     Document Type: Article
Times cited : (31)

References (11)
  • 1
    • 78650301478 scopus 로고    scopus 로고
    • Brentuximab vedotin: Delivering an antimitotic drug to activated lymphoma cells
    • S.M. Ansell Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells Expert Opin Investig Drugs 20 2011 99 105
    • (2011) Expert Opin Investig Drugs , vol.20 , pp. 99-105
    • Ansell, S.M.1
  • 2
  • 3
    • 78049515807 scopus 로고    scopus 로고
    • Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas
    • A. Younes, N.L. Bartlett, J.P. Leonard Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas N Engl J Med 363 2010 1812 1821
    • (2010) N Engl J Med , vol.363 , pp. 1812-1821
    • Younes, A.1    Bartlett, N.L.2    Leonard, J.P.3
  • 4
    • 55249097877 scopus 로고    scopus 로고
    • Novel peptide linkers for highly potent antibody-auristatin conjugate
    • S.O. Doronina, T.D. Bovee, D.W. Meyer Novel peptide linkers for highly potent antibody-auristatin conjugate Bioconjug Chem 19 2008 1960 1963
    • (2008) Bioconjug Chem , vol.19 , pp. 1960-1963
    • Doronina, S.O.1    Bovee, T.D.2    Meyer, D.W.3
  • 5
    • 77950099811 scopus 로고    scopus 로고
    • Emerging immunotherapies targeting CD30 in Hodgkin's lymphoma
    • H.P. Gerber Emerging immunotherapies targeting CD30 in Hodgkin's lymphoma Biochem Pharmacol 79 2010 1544 1552
    • (2010) Biochem Pharmacol , vol.79 , pp. 1544-1552
    • Gerber, H.P.1
  • 8
    • 47049084821 scopus 로고    scopus 로고
    • ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International peripheral T-cell lymphoma project
    • K.J. Savage, N.L. Harris, J.M. Vose ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International peripheral T-cell lymphoma project Blood 111 2008 5496 5504
    • (2008) Blood , vol.111 , pp. 5496-5504
    • Savage, K.J.1    Harris, N.L.2    Vose, J.M.3
  • 9
    • 33750702172 scopus 로고    scopus 로고
    • Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting
    • J.R. Fromm, S.J. Kussick, B.L. Wood Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting Am J Clin Pathol 126 2006 764 780
    • (2006) Am J Clin Pathol , vol.126 , pp. 764-780
    • Fromm, J.R.1    Kussick, S.J.2    Wood, B.L.3
  • 10
    • 68449083857 scopus 로고    scopus 로고
    • Lymphocyte depleted Hodgkin lymphoma: An evaluation with immunophenotyping and genetic analysis
    • G.W. Slack, J.A. Ferry, R.P. Hasserjian Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis Leuk Lymphoma 50 2009 937 943
    • (2009) Leuk Lymphoma , vol.50 , pp. 937-943
    • Slack, G.W.1    Ferry, J.A.2    Hasserjian, R.P.3
  • 11
    • 0022446735 scopus 로고
    • Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms
    • A.A. Epenetos, D. Snook, H. Durbin Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms Cancer Res 46 1986 3183 3191
    • (1986) Cancer Res , vol.46 , pp. 3183-3191
    • Epenetos, A.A.1    Snook, D.2    Durbin, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.